Bruce R. Chizen
Bruce R. Chizen's purchase track record
Bruce R. Chizen has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/13/2023 | CHPT | $2.90M | -58.6% | -69.3% | +15.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Oracle: No Recent Company News. Oracle has not had any new company‑specific announcements in the past week. The recent news items listed relate to other technology firms and do not directly affect Oracle’s operations or outlook. Investors can continue to rely on existing fundamentals and market data for guidance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Synopsys Launches $1B Buyback and AI Chip Libraries. Synopsys announced a $1 billion accelerated share buyback, signaling management confidence in the company's value. The firm also introduced AI chipmaking libraries to support semiconductor workflows, aligning with broader industry trends in AI-defined manufacturing. Analysts have responded by raising price targets, with the current average sitting well above the stock's 52-week low.
Transaction History
| CHPT | ▲ Buy | Grant | 18,370 | $0 | 7/21/2026 | View on chart |
| CHPT | ▲ Buy | Grant | 6,680 | $0 | 7/21/2026 | View on chart |
| CHPT | ▲ Buy | Grant | 5,010 | $0 | 7/21/2026 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 2,114 | — | 5/31/2026 | View on chart |
| SNPS | ▲ Buy | Grant | 453 | $0 | 4/16/2026 | View on chart |
| CHPT | ▲ Buy | Grant | 254,785 | $0 | 7/8/2025 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 2,986 | — | 5/31/2025 | View on chart |
| SNPS | ▲ Buy | Grant | 491 | $0 | 4/10/2025 | View on chart |
| CHPT | ▲ Buy | Grant | 115,552 | $0 | 7/9/2024 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 3,303 | — | 5/31/2024 | View on chart |
| SNPS | ▲ Buy | Grant | 356 | $0 | 4/10/2024 | View on chart |
| CHPT | ▲ Buy | Open Market | 500,000 | $2.9M | 9/13/2023 | View on chart |
| CHPT | ▲ Buy | Grant | 21,925 | $0 | 7/18/2023 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 4,866 | — | 5/31/2023 | View on chart |
| SNPS | ▲ Buy | Grant | 464 | $0 | 4/12/2023 | View on chart |
| CHPT | ▲ Buy | Option Exercise | 10,000 | $8K | 10/3/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 10,000 | $151K | 10/3/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 10,000 | $151K | 10/3/2022 | View on chart |
| CHPT | ▲ Buy | Option Exercise | 10,000 | $8K | 9/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 6,300 | $104K | 9/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 3,700 | $63K | 9/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 19 | $299 | 9/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 6,500 | $107K | 9/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 3,481 | $59K | 9/8/2022 | View on chart |
| CHPT | ▲ Buy | Option Exercise | 4,300 | $3K | 8/2/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 4,300 | $65K | 8/2/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 4,300 | $65K | 8/2/2022 | View on chart |
| CHPT | ▲ Buy | Option Exercise | 5,700 | $4K | 8/1/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 5,700 | $86K | 8/1/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 5,700 | $86K | 8/1/2022 | View on chart |
| CHPT | ▲ Buy | Option Exercise | 10,000 | $8K | 7/28/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 10,000 | $151K | 7/28/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 10,000 | $151K | 7/28/2022 | View on chart |
| CHPT | ▲ Buy | Grant | 13,563 | $0 | 7/12/2022 | View on chart |
| CHPT | ▲ Buy | Option Exercise | 20,000 | $15K | 6/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 20,000 | $313K | 6/8/2022 | View on chart |
| CHPT | ▼ Sell | Open Market | 20,000 | $313K | 6/8/2022 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 4,445 | — | 5/31/2022 | View on chart |
| SNPS | ▲ Buy | Grant | 563 | $0 | 4/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
ChargePoint Raises Price Target After Strong Q2 Results
ChargePoint's second‑quarter earnings were stronger than expected, prompting UBS to lift its price target to $9. The company’s Express Solo Fast Charger has drawn attention from executives, and analysts note the firm is outpacing peers in the auto‑tires‑trucks segment. These developments suggest growing demand for electric‑vehicle charging infrastructure.
ChargePoint Raises Price Target After Strong Q2 Results. ChargePoint's second‑quarter earnings were stronger than expected, prompting UBS to lift its price target to $9. The company’s Express Solo Fast Charger has drawn attention from executives, and analysts note the firm is outpacing peers in the auto‑tires‑trucks segment. These developments suggest growing demand for electric‑vehicle charging infrastructure.